Design of a novel hydrogel-based intelligent system for controlled drug release

被引:166
作者
He, HY [1 ]
Cao, X [1 ]
Lee, LJ [1 ]
机构
[1] Ohio State Univ, Dept Chem Engn, Columbus, OH 43210 USA
关键词
intelligent drug delivery system (DDS); pH-sensitive hydrogel; bilayered self-folding design; mucoadhesion;
D O I
10.1016/j.jconrel.2003.12.004
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The present work focused on the design of an assembled drug delivery system (DDS) to provide multifunctions, such as drug protection, self-regulated oscillatory release, and targeted uni-directional delivery by a bilayered self-folding gate and simple surface mucoadhesion. In this device, a pH-sensitive hydrogel together with a poly(hydroxyethyl methacrylate) (HEMA) barrier was used as a gate to control drug release. In addition, poly(HEMA) coated with poly(ethylene oxide)/poly(propylene oxide)/poly(ethylene oxide) (PEO-PPO-PEO) surfactant was utilized to enhance mucoadhesion on the device surface. The release profiles of two model drugs, acid orange 8 (AO8) and bovine serum albumin (BSA) were studied in this assembled system, which compared with the conventional drug-entrapped carriers and enteric-coating systems. Furthermore, targeted unidirectional release was demonstrated in a side-by-side diffusion cell. In conclusion, for such an assembled device, the poly(HEMA) layer not only affects the folding direction but also serves as a barrier to protect the model drugs. The release time can be controlled by the thickness of the bilayered gate and the drug reservoir. Due to the reversible swelling behavior of poly(methyacrylic acid-g-ethylene glycol) (p(MAA-g-EG)) gels, the bilayered gate can sense the environmental pH change and achieve an oscillatory release pattern. Moreover, the local targeting and uni-directional release have been successfully demonstrated in vitro. (C) 2004 Elsevier B.V All rights reserved.
引用
收藏
页码:391 / 402
页数:12
相关论文
共 33 条
[1]  
ASCENTIIS D, 1995, J CONTROL RELEASE, V33, P197
[2]   Hydrogel implants for methotrexate obtained by ionizing radiation [J].
Beyssac, E ;
Bregni, C ;
Aiache, JM ;
Gerula, S ;
Smolko, E .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1996, 22 (05) :439-444
[3]  
Brögmann B, 2001, DRUGS PHARM SCI, V115, P1
[4]   Design of a Self-Regulated Drug Delivery Device [J].
Cao, Xia ;
Lai, Siyi ;
Lee, L. James .
BIOMEDICAL MICRODEVICES, 2001, 3 (02) :109-117
[5]   A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye [J].
Cohen, S ;
Lobel, E ;
Trevgoda, A ;
Peled, Y .
JOURNAL OF CONTROLLED RELEASE, 1997, 44 (2-3) :201-208
[6]   Development and characterization of a novel peroral peptide drug delivery system [J].
Dorkoosh, FA ;
Verhoef, JC ;
Borchard, G ;
Rafiee-Tehrani, M ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 2001, 71 (03) :307-318
[7]  
DRAYE JP, 1997, P INT S CONTR REL BI, V24, P467
[8]   Engineering liposomes for drug delivery: Progress and problems [J].
Gregoriadis, G .
TRENDS IN BIOTECHNOLOGY, 1995, 13 (12) :527-537
[9]  
HASSAN CM, 1999, ACS SYM SER, V728, P54
[10]  
Heller J., 1996, BIOMATERIALS SCI INT, P346